LAVAL, Quebec, April 28, 2021 /PRNewswire/ -- Bausch Health
Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company")
today announced the election of the 13 directors nominated at its
2021 annual meeting of shareholders held on April 27, 2021. The detailed results of the vote
for the election of directors are set out below:
|
Name
|
For
|
Withheld
|
Broker
Non-Votes
|
|
Richard U. De
Schutter
|
200,369,606
|
5,768,489
|
60,380,196
|
|
D. Robert
Hale
|
196,356,636
|
9,781,459
|
60,380,196
|
|
Brett
Icahn
|
196,491,749
|
9,646,346
|
60,380,196
|
|
Dr. Argeris (Jerry)
N. Karabelas
|
198,928,372
|
7,209,723
|
60,380,196
|
|
Sarah B.
Kavanagh
|
203,110,562
|
3,027,533
|
60,380,196
|
|
Steven D.
Miller
|
200,857,243
|
5,280,852
|
60,380,196
|
|
Joseph C.
Papa
|
198,455,884
|
7,682,211
|
60,380,196
|
|
John A.
Paulson
|
205,191,567
|
946,528
|
60,380,196
|
|
Robert N.
Power
|
177,088,588
|
29,049,507
|
60,380,196
|
|
Russel C.
Robertson
|
197,810,980
|
8,327,115
|
60,380,196
|
|
Thomas W. Ross,
Sr.
|
186,746,866
|
19,391,229
|
60,380,196
|
|
Andrew C. von
Eschenbach, M.D.
|
205,016,196
|
1,121,899
|
60,380,196
|
|
Amy B. Wechsler,
M.D.
|
200,266,488
|
5,871,607
|
60,380,196
|
At the annual meeting of shareholders, shareholders also
approved in a non-binding advisory vote the compensation of the
Company's named executive officers and appointed
PricewaterhouseCoopers LLP as the Company's independent registered
public accounting firm until the close of the Company's 2022 annual
meeting of shareholders.
The final vote tabulation on all matters voted on at the meeting
will be reported to the U.S. Securities and Exchange Commission on
a current report on Form 8-K, and such report will be made
available on the Company's website at www.bauschhealth.com.
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company
whose mission is to improve people's lives with our health care
products. We develop, manufacture and market a range of
pharmaceutical, medical device and over-the-counter products,
primarily in the therapeutic areas of eye health, gastroenterology
and dermatology. We are delivering on our commitments as we build
an innovative company dedicated to advancing global health. More
information can be found at www.bauschhealth.com.
|
Investor
Contact:
|
Media
Contact:
|
|
Arthur
Shannon
|
Lainie
Keller
|
|
arthur.shannon@bauschhealth.com
|
lainie.keller@bauschhealth.com
|
|
(514)
856-3855
|
(908)
927-1198
|
|
(877) 281-6642 (toll
free)
|
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/bausch-health-announces-2021-annual-meeting-of-shareholder-results-301278480.html
SOURCE Bausch Health Companies Inc.